Analysis of the GEPIA dataset demonstrated that IRF1 exhibited higher median expression levels in AML compared to other tumor types, with elevated expression levels observed in cancer cells compared to normal cells (Supplementary Fig. 7A). This evidence concerns the gene IRF1 and acute myeloid leukemia.